Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Navamedic
Deal Size : Undisclosed
Deal Type : Agreement
Navamedic ASA Acquires Innovative Antibiotic Product for Hospital Use in The Nordic Region
Details : Clindamycin is a well-established antibiotic used in treatment of severe infections, including staphylococcal bone and joint infections, chronic sinusitis and infections of the lower respiratory tract.
Product Name : Clindamycin-Generic
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
November 23, 2022
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Navamedic
Deal Size : Undisclosed
Deal Type : Agreement
Reset All
